QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease.

Song, Fucheng; Sun, Haoyang; Ma, Xiaofang; Wang, Wei; Luan, Mingyuan; Zhai, Honglin; Su, Guanmin; Liu, Yantao

Song, Fucheng; Sun, Haoyang; Ma, Xiaofang; Wang, Wei; Luan, Mingyuan; Zhai, Honglin; Su, Guanmin; Liu, Yantao.

Afiliação

Song F; Qingdao Municipal Center for Disease Control and Prevention, Qingdao, China.
Sun H; Department of Traditional Chinese Medicine, Songshan Hospital of Qingdao University, Qingdao, China.
Ma X; Qingdao Municipal Center for Disease Control and Prevention, Qingdao, China.
Wang W; Qingdao Municipal Center for Disease Control and Prevention, Qingdao, China.
Luan M; Qingdao University Medical College, Qingdao, China.
Zhai H; Department of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China.
Su G; Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
Liu Y; Qingdao Municipal Center for Disease Control and Prevention, Qingdao, China.

Front Pharmacol ; 14: 1185004, 2023.

Article em En | MEDLINE | ID: mdl-37266150

Palavras-chave

QSAR; SARS-CoVs; drugs design; molecular docking; unsymmetrical aromatic disulfides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google